Maria Teresa Faria

Prof. Maria Teresa Faria

Department of Nuclear Medicine, Unidade Local de Saúde de São João, Porto, Portugal
+2
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Epilepsy & Behavior
Verified
Journal Article
Closed access
Maria Teresa FariaMaria Teresa Faria
Maria Teresa Faria
SRSusana Rodrigues
Susana Rodrigues
MCManuel Campelo
Manuel Campelo
DDDuarte Dias
Duarte Dias
RRRicardo Rego
Ricardo Rego
EMElisabete Martins
Elisabete Martins

1 April 2019 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
AFAna Fernandes
Ana Fernandes
Maria Teresa FariaMaria Teresa Faria
Maria Teresa Faria
AOAna Oliveira
Ana Oliveira
PCP. Barata Coelho
P. Barata Coelho
JPJ.G. Pereira
J.G. Pereira

1 December 2021 in Epilepsy Research
Verified
Journal Article
Closed access
Maria Teresa FariaMaria Teresa Faria
Maria Teresa Faria
SRSusana Rodrigues
Susana Rodrigues
MCManuel Campelo
Manuel Campelo
DDDuarte Dias
Duarte Dias
RRRicardo Rego
Ricardo Rego
EMELISABETE MARTINS
ELISABETE MARTINS

1 August 2020 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
Maria Teresa FariaMaria Teresa Faria
Maria Teresa Faria
RRRicardo Rego
Ricardo Rego
HRHelena Rocha
Helena Rocha
FSFrancisca Sá
Francisca Sá
RFRui Farinha
Rui Farinha
EMELISABETE MARTINS
ELISABETE MARTINS

Verified
Journal Article
Open access
PDF file
SPSofia Pimenta
Sofia Pimenta
LSLuís Daniel Santos
Luís Daniel Santos
AMAna Martins
Ana Martins
Janete Quelhas-SantosJanete Quelhas-Santos
Janete Quelhas-Santos
IFInês Fortuna
Inês Fortuna
EMELISABETE MARTINS
ELISABETE MARTINS
Background: Carpal tunnel syndrome (CTS) has emerged as an early indicator of cardiac amyloidosis (CA) caused by transthyretin-associated (ATTR) mutations, possibly linked to adverse cardiovascular outcomes. This case series examines the relationship between idiopathic CTS and CA imaging diagnosis. Methods: Twenty-two patients from the cross-sectional study CarPoS (NCT05409833) were included. These patients underwent physical evaluation, laboratory exams, electrocardiography, echocardiography, cardiac magnetic resonance (CMR) imaging, and scintigraphy with 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid. Results: Four of the twenty-two patients included had ATTR cardiomyopathy. These patients presented left-ventricle hypertrophy and signs of infiltrative cardiomyopathy in echocardiograms and late gadolinium enhancement in CMR images without having any cardiovascular symptoms. Conclusions: Our findings suggest a high prevalence of CA in patients with bilateral idiopathic CTS, highlighting the importance of screening for CA in patients with CTS. Early detection could significantly impact patient prognosis, underscoring the need for further research into diagnostic and therapeutic strategies.

1 March 2012 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SOSílvia Marta Oliveira
Sílvia Marta Oliveira
EMELISABETE MARTINS
ELISABETE MARTINS
AOAna Oliveira
Ana Oliveira
TPTeresa Pinho
Teresa Pinho
CGCristina Gavina
Cristina Gavina
MMMaria Júlia Maciel
Maria Júlia Maciel
Left ventricular noncompaction is an unusual but increasingly recognized cardiomyopathy, the etiology of which is still not definitely established. Clinical presentation includes a wide spectrum of scenarios, including heart failure, thromboembolism and malignant arrhythmias, with half of deaths occurring suddenly. Early detection of LVNC is therefore essential to prevent sudden cardiac death. To our knowledge, this is the first report of the presence of cardiac sympathetic nervous dysfunction, assessed by 123iodine-metaiodobenzylguanidine myocardial scintigraphy, in a patient with LVNC, preserved left ventricular systolic function and exercise-induced nonsustained ventricular tachycardia. This finding may be related to the increased arrhythmic risk observed in this cardiomyopathy, giving a new insight into the pathophysiology of LVNC.